InvestorsObserver
Sign Up Login

CNBX Cnbx Pharmaceuticals Inc

$0.01 $0.00 (20.00%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

CNBX Stock Analysis Overview

What this means: Cnbx Pharmaceuticals Inc (CNBX) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives CNBX a rank of 9. Our methodology considers analysis of the company's financial situation and how it has traded recently. CNBX rank of 9 means that it ranks below 91% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

CNBX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

CNBX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

CNBX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

CNBX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

CNBX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

CNBX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

CNBX Stock Analysis Overview

What this means: Cnbx Pharmaceuticals Inc (CNBX) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives CNBX a rank of 9. Our methodology considers analysis of the company's financial situation and how it has traded recently. CNBX rank of 9 means that it ranks below 91% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full CNBX report

CNBX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

CNBX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

CNBX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

CNBX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

CNBX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

CNBX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Cnbx Pharmaceuticals Inc (CNBX) Analyst Forecast

CNBX Price, Volume, Earnings, and Dividend Date

  • Last Price $0.01
  • Previous Close $0.01
  • Change $0.00
  • Open $0.01
  • Volume 433,978
  • Avg. Volume (100-day) 281,795
  • Market Cap 373,336
  • Days Range 0.0089 - 0.012
  • 52-week Range 0.01 - 0.05
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS 0.98
  • Earnings Date —
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta -9.022
  • PEG Ratio —

Cnbx Pharmaceuticals Inc (CNBX) Company Description

Cannabics Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing advanced HTS technology and personalized bioinformatics tools. The company's main focus is the development of therapies and biotechnological tools aimed at diverse ailments and human malignancies. The firm's main product is cannabis oil capsule. Its advanced tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.

Cnbx Pharmaceuticals Inc (CNBX) Stock Chart

View Interactive CNBX chart

My Watchlists

Top Stocks in Biotechnology